649758-61-2 Usage
Uses
Used in Pharmaceutical Industry:
(E)-5,6-Dimethoxy-3-(4-hydroxybenzylidene)-1H-indolin-2-one is used as a pharmaceutical compound for its potential anti-inflammatory, antibacterial, and antifungal properties. Its diverse biological activities make it a promising candidate for the development of new drugs and therapies to treat various conditions.
Used in Anticancer Applications:
(E)-5,6-Dimethoxy-3-(4-hydroxybenzylidene)-1H-indolin-2-one is used as an anticancer agent for its potential to target and inhibit cancer cell growth. Its specific mechanisms of action and interactions with cellular pathways are currently under investigation, with the aim of developing more effective cancer treatments.
Used in Drug Development:
(E)-5,6-Dimethoxy-3-(4-hydroxybenzylidene)-1H-indolin-2-one is used as a key component in the development of new drugs and pharmaceutical compounds. Its unique chemical structure and potential pharmacological properties make it an attractive candidate for further research and development in the field of medicinal chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 649758-61-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,4,9,7,5 and 8 respectively; the second part has 2 digits, 6 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 649758-61:
(8*6)+(7*4)+(6*9)+(5*7)+(4*5)+(3*8)+(2*6)+(1*1)=222
222 % 10 = 2
So 649758-61-2 is a valid CAS Registry Number.
649758-61-2Relevant academic research and scientific papers
INDOLINONE DERIVATIVES AS RECEPTOR TYROSINE KINASE IHIBITORS
-
Page/Page column 18-19, (2008/06/13)
Novel derivatives of compound (E)-1,3-dihydro-5,6-dimethoxy-3-[(4-hydroxyphenyl)methylene]-2H-indol-2-one and the use thereof for the preparation of medicaments for the treatment of tumors in which the tyrosine kinase activity proteins Met, PDGF-R, FGF-R1
Indolinone derivatives
-
Page/Page column 7, (2008/06/13)
Novel derivatives of compound (E)-1,3-dihydro-5,6-dimethoxy-3-[(4-hydroxyphenyl)methylene]-2H-indol-2-one and the use thereof for the preparation of medicaments for the treatment of tumors in which the tyrosine kinase activity proteins Met, PDGF-R, FGF-R1
